SCHEMBL7703064

SCHEMBL7703064

Nc1cc(-c2cccc(F)c2)cc2nc(-c3ccccc3)nn12

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
NPC1 O15118 2/20 0.45
HPGD P15428 2/20 0.45
RAB9A P51151 2/20 0.45
NFKB1 P19838 1/20 0.45
HTT P42858 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
DPP4 P27487 1/20 0.44
ADORA3 P0DMS8 3/20 0.43
KMT2A Q03164 4/20 0.42
KDM4E B2RXH2 3/20 0.42
MEN1 O00255 3/20 0.42
MAPT P10636 2/20 0.42
GAA P10253 1/20 0.42
ADORA2A P29274 4/20 0.41
TAAR1 Q96RJ0 1/20 0.41
ADORA1 P30542 3/20 0.40
AMY1A P0DUB6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7423524 0.87 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7709122 0.86 MAOA (0.47) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7708837 0.85 GRM5 (0.52) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7485299 0.83 ADORA2A (0.56) ADORA2A
SCHEMBL7711711 0.83 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7703193 0.82 ADORA2A (0.46) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7431271 0.81 AMY1A (0.50) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7705853 0.81 ADORA2A (0.53) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7427474 0.81 SMN1; SMN2 (0.47) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A
SCHEMBL7703071 0.81 ADORA2A (0.46) ALDH1A1SMN1; SMN2NPC1HPGDRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed